PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 14 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
In vivo studies show protective effects against various neurological diseases [PMID:27540320].
Long-term treatment in obese diabetic rat models reversed glucose and lipid levels, as well as tricarboxylic acid cycle and amino acid metabolic disorders [PMID:26775274]. Systematic review of ulam indicates C. asiatica is one of the plants studied for modulating blood glucose levels in humans [PMID:25164446].
Hexane extract of pegaga showed inhibitory potential against angiotensin I-converting enzyme (ACE) in vitro [PMID:22135867].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 27540320 (2016) — Recent Updates in Neuroprotective and Neuroregenerative Potential of Centella asiatica. · The Malaysian journal of medical sciences : MJMS
- 2.PMID: 25164446 (2014) — Effectiveness of traditional Malaysian vegetables (ulam) in modulating blood glucose levels. · Asia Pacific journal of clinical nutrition
- 3.PMID: 26775274 (2016) — Metabolic alteration in obese diabetes rats upon treatment with Centella asiatica extract. · Journal of ethnopharmacology
- 4.PMID: 20589353 (2010) — Antispermatogenic and antifertility effect of Pegaga (Centella asiatica L) on the testis of male Sprague-Dawley rats. · La Clinica terapeutica
- 5.PMID: 22084897 (2012)